IGEA S.p.A. is an Italian biomedical company established in 1980 and based in Carpi, Modena. It is recognized as a leader in biophysical therapies, focusing on the interactions between biological systems and physical stimuli for therapeutic applications. The company emphasizes research-driven innovation in medical devices and therapies, supported by a dedicated Research and Development team that has produced over 600 scientific papers. IGEA offers a range of therapies, including orthopaedic therapies for fracture healing and joint protection, oncological therapies utilizing reversible electroporation, and gene therapies, including nucleic acid vaccinations. Key products include Biostim, OsteoSpine, I-ONE, CLINIPORATOR, and FULL Genedrive. The company is committed to advancing patient care through scientific research and innovation, guided by principles of honesty and moral commitment. With a workforce of about 125 employees, IGEA also maintains a Code of Ethics for transparency and compliance, and its UK branch publishes a Carbon Reduction Plan for environmental management.